The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
Artificial intelligence could reduce clinicians' administrative work and accelerate drug innovation, but the new technology needs oversight, said lawmakers, who met last week to discuss benefits as well as possible threats of AI.
More than one-third of companies are disclosing individual pay ranges to employees, and an even larger number (46%) are planning or considering doing so in the future.
The comprehensive new bill, which advanced on Wednesday, would introduce more transparency, such as requiring pharmacies to report medication costs – and would be paired with another PBM bill that passed earlier this year.
After lawmakers called for oversight over Medicare Advantage marketing practices three weeks ago, the Centers for Medicare and Medicaid Services is now proposing to limit the compensation brokers can receive from insurers.
More details were announced last week on Pres. Biden's new student loan forgiveness plan, which aims to cancel some or all student debt for specific types of borrowers, like those whose balances exceed what they originally owed.
Two Republican lawmakers sent a letter to the FDA commissioner, seeking a staff-level briefing on the short supply of 128 drugs, including "life-supporting medications" that treat infections, heart failure and cancer, by Nov. 9.
The Centers for Medicare & Medicaid Services finalized rules on Thursday with sweeping implications for providers, including Medicare reimbursement rates for hospital outpatient sites and doctor's offices.